TriPhos Therapeutics, Inc.

Platform-based systemic silencing of aberrantly expressed Human genes to reduce Inflammation, TBI and Opioid Dependence.

  • Stage Product In Development
  • Industry Biotechnology
  • Location San Diego, CA, USA
  • Currency USD
  • Founded December 2011
  • Employees 2
  • Incorporation Type C-corp
  • Website http:\\triphosthera.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free